BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//ox.ac.uk//NONSGML oxford.event//EN
X-WR-TIMEZONE:Europe/London
BEGIN:VTIMEZONE
TZID:Europe/London
X-LIC-LOCATION:Europe/London
BEGIN:DAYLIGHT
DTSTART:19700329T010000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=3
TZNAME:BST
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
END:DAYLIGHT
BEGIN:STANDARD
DTSTART:19701025T020000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=10
TZNAME:GMT
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
SUMMARY:IDEU Seminar - Group B Streptococcus and other difficult to licens
 e vaccines – what is the problem?
DTSTART;TZID=Europe/London:20260615T130000
DTEND;TZID=Europe/London:20260615T140000
DTSTAMP:20260515T150800Z
UID:d5a7afa0-6c19-f111-8342-7c1e527a0d5f
CREATED:20260306T145652Z
DESCRIPTION:Summary: "Group B Streptococcus exemplifies the scientific\, r
 egulatory\, and policy challenges of licensing vaccines where traditional 
 efficacy trials are difficult. This talk explores barriers including low-i
 ncidence endpoints\, lack of correlates of protection\, and ethical constr
 aints\, and highlights emerging solutions such as immunological endpoints\
 , serocorrelates\, and innovative trial and regulatory pathways.\nand bio:
 "\n\nBio: Professor Kirsty Le Doare is a paediatric infectious disease spe
 cialist and vaccinologist at City St George’s\, University of London. Sh
 e leads global research on maternal and neonatal immunisation\, focusing o
 n Group B Streptococcus\, and advises WHO on vaccine development\, policy\
 , and implementation in low- and middle-income countries.\n\n\nProfessor K
 irsty Mehring-Le Doare\nWorld Health Organisation & St. George's\nhttps://
 www.sgul.ac.uk/profiles/kirsty-le-doare
LAST-MODIFIED:20260428T140748Z
LOCATION:Big Data Institute - Seminar rooms\, Seminar rooms Big Data Insti
 tute Old Road Campus Oxford Oxfordshire OX3 7LF United Kingdom
SPEAKER:Professor Kirsty Mehring-Le Doare
END:VEVENT
END:VCALENDAR